E. Bateman (Cape Town, South Africa), R. Russell (Lymington (Hampshire), United Kingdom)
Blood eosinophilia in patients with COPD, a real life evaluation
M. Baptista Duarte Barata (Almada, Portugal), T. Martín (Almada, Portugal), R. Gomes (Almada, Portugal), H. Grumete (Almada, Portugal), F. Menezes (Almada, Portugal), J. Duarte (Almada, Portugal)
|     |
Relationship between blood eosinophil levels and severity of COPD
A. Ben Saad (Monastir, Tunisia), R. Khemakhem (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia)
| |
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
M. Ghebre (Leicester, United Kingdom), P. Pang (Singapore, Singapore), S. Diver (Leicester, United Kingdom), D. Desai (Leicester, United Kingdom), M. Bafadhel (Oxford, United Kingdom), K. Haldar (Leicester, United Kingdom), T. Kebadze (London, United Kingdom), S. Cohen (Cambridge, United Kingdom), P. Newbold (Cambridge, United Kingdom), L. Rapley (Cambridge, United Kingdom), J. Woods (Cambridge, United Kingdom), P. Rugman (Cambridge, United Kingdom), I. Pavord (Oxford, United Kingdom), S. Johnston (London, United Kingdom), M. Barer (Leicester, United Kingdom), R. May (Cambridge, United Kingdom), C. Brightling (Leicester, United Kingdom)
| |
10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death
T. Harju (Oulu, Finland), L. Peltonen (Oulu, Finland), H. Pätsi (Oulu, Finland), R. Bloigu (Oulu, Finland)
| |
Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap
J. Shim (Seoul, Republic of Korea), J. Oh (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), Y. Lee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), G. Hur (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), K. Kang (Seoul, Republic of Korea)
| |
GC MS based untargeted metabolomics for understanding the pathophysiology of asthma COPD overlap (ACO)
N. Ghosh (Kharagpur, India), S. Rathnakaram (Kharagpur, India), S. Kaushik (New Delhi, India), R. Arya (New Delhi, India), R. Nanda (New Delhi, India), P. Bhattacharyya (Newtown, Kolkata, India), S. Roy Chowdhury (Kolkata, India), R. Banerjee (Kharagpur, India), K. Chaudhury (Kharagpur, India)
| |
Identifying asthma features in severe COPD
S. Matthes (Munich, Germany), J. Stadler (Munich, Germany), J. Barton (Munich, Germany), H. Villena-Hermoza (Munich, Germany), M. Frankenberger (Munich, Germany), N. Kneidinger (Munich, Germany), K. Milger (Munich, Germany), P. Probst (Munich, Germany), G. Leuschner (Munich, Germany), D. Muncker (Munich, Germany), P. Arnold (Munich, Germany), A. Koch (Munich, Germany), J. Behr (Munich, Germany), C. Neurohr (Stuttgart, Germany)
| |
Comparing the different diagnostic criteria of Asthma and COPD overlap
Y. Jo (Seoul, Republic of Korea), M. Kang (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), S. Han (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea)
| |
“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
M. Bartoli (Pisa, Italy), M. Daniele (Pisa, Italy), D. Nieri (Pisa, Italy), M. Roggi (Pisa, Italy), M. Bradicich (Pisa, Italy), R. Del Cesta (Pisa, Italy), C. Cardini (Pisa, Italy), S. Cianchetti (Pisa, Italy), B. Vagaggini (Pisa, Italy), P. Paggiaro (Pisa, Italy)
| |
Stability of the eosinophilic phenotype in stable and exacerbated COPD
D. Schumann (Basel, Switzerland), M. Tamm (Basel, Switzerland), K. Kostikas (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD
Y. Kaptan (Izmir, Turkey), A. Suner (Izmir, Turkey), A. Gürgün (Izmir, Turkey), A. Sayiner (Izmir, Turkey)
| |
Serum Club cell16 levels as a biomarker in tobacco-smoke COPD and biomass-smoke COPD
V. Veerapaneni (mysore, India), J. Bs (mysore, India), C. S.K (mysore, India), L. K.S (mysore, India), K. Sivakoti (mysore, India), R. Tirumulappa (mysore, India), M. P.A (mysore, India)
| |
Interleukin-26 in airway morbidities of long-term tobacco smokers
K. Che (Stockholm, Sweden), E. Tufvesson (Lund, Sweden), S. Tengvall (Gothenburg, Sweden), E. Lappi-Blanco (Oulu, Finland), R. Kaarteenaho (Oulu, Finland), B. Levanen (Stockholm, Sweden), M. Ekberg (Lund, Sweden), A. Brauner (Stockholm, Sweden), å. Wheelock (Stockholm, Sweden), L. Bjermer (Lund, Sweden), M. SköLd (Stockholm, Sweden), A. LindéN (Stockholm, Sweden)
| |
Bronchial fibrocyte accumulation in COPD patients
I. Dupin (Bordeaux, France), M. Thumerel (Bordeaux, France), E. Maurat (Bordeaux, France), F. Coste (Bordeaux, France), H. Begueret (Bordeaux, France), T. Trian (Bordeaux, France), M. Montaudon (Bordeaux, France), R. Marthan (Bordeaux, France), P. Girodet (Bordeaux, France), P. Berger (Bordeaux, France)
| |
Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients
J. COHEN (Grenoble, France), G. Ferretti (Grenoble, France), R. Tamisier (Grenoble, France), M. Benmerad (Grenoble, France), S. Bailly (Grenoble, France), C. Ozcelik (Grenoble, France), E. Reymond (Grenoble, France), S. Bayat (Grenoble, France), J. Pépin (Grenoble, France)
| |